Moleculin Biotech Inc (NAS:MBRX)
$ 1.77 -0.05 (-2.75%) Market Cap: 5.65 Mil Enterprise Value: -3.21 Mil PE Ratio: 0 PB Ratio: 0.71 GF Score: 36/100

Q2 2024 Moleculin Biotech Inc Earnings Call Transcript

Aug 06, 2024 / 12:30PM GMT
Release Date Price: $2.2 (-8.71%)
Operator

Greetings and welcome to the conference call where Moleculin Biotech discusses plans for MIRACLE Phase 3 pivotal trial. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Jenene Thomas.

Jenene Thomas
Moleculin Biotech Inc - Investor Relations

Thank you, operator. At this time, I'd like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations, or future projections. These are forward-looking statements and involve risks and uncertainties.

Forward-looking statements on this call are made pursuant to the Safe Harbor provisions of the federal securities laws and are based on Moleculin's current expectations, and actual results could differ materially. As a result, you should not place undue reliance on any forward-looking statements.

Some of the factors that could cause actual results to differ materially from these contemplated by such forward-looking statements are discussed in the periodic reports

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot